Cavion, LLC
  • Founded: 2005
  • CEO: Andrew Krouse
  • Size of Facility: 3000 sq ft
  • Company Size: 12
  • Funding Source: Investor Funded, Privately Held
  • Development Stage: Phase 1-2 Clinical Trials

Cavion LLC is a privately held clinical stage platform pharmaceutical company creating therapies engaging the T-type calcium channel for the treatment of certain neurologic, oncologic and rare diseases.